| Buprenorphine hydrochloride and Naloxone hydrochloride dihydrate | Orexo Pharma | ||
| 2.9/0.71mg,0.7/0.18mg,8.6/2.1mg,11.4/2.9mg,1.4/0.3 Tablets |
Less Than $1000 mn
|
||
|
Less Than 5
|
Less Than 5
|
||
| None |
Less Than 5
|
||
| None | None | ||
| Indicated for the maintenance treatment of opioid dependence and should be used as part of a complete treatment plan to include counseling and psychosocial support. | |||
|
Yes
| |||
| Zubsolv | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| ******* | **** ** ** | *** ********* | *** ********* | ********* | *** ** ** / **** ** ** | ********* | *** ********* (***** ******) | *** ********* (***** ******) | *** ********* (***** ******) | *** ********* (***** ******) |
| *** ****** | *** ********* | ********* | ********* | **** ** ** / ******* | ********* | ********* | ********* | **** ** ** / ******* | ********* | ********* |
| *****-********* ************** *********** *** *** ********* ** ****** ********** | *****-********* ************** *********** *** *** ********* ** ****** ********** | *****-********* ************** *********** *** *** ********* ** ****** ********** | *****-********* ************** *********** *** *** ********* ** ****** ********** | *********-**** *** **** | ***-******** ************** *********** ********** ******* | ***-******** ************** *********** ********** ******* | *****-********* ************** *********** *** *** ********* ** ****** ********** | *****-********* ************** *********** *** *** ********* ** ****** ********** | *****-********* ************** *********** *** *** ********* ** ****** ********** |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ******* | *** / ** | *** *, **** | **** ** ** *** ** | **** | ** *** **, **** |
| *** ****** | ** / ** | *** **, **** | **** ** ** / ******* | ********* ******** | ** ***, **** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|